Innovative Therapeutic Approaches for Post-Infectious Diseases

Joachim Gerlach’s research on Long COVID represents a significant contribution to our understanding of this complex post-viral disease. His account, which links persistent infection, autoimmunity and vascular pathologies, thus provides a comprehensive framework for understanding Long COVID.
The emphasis on the multisystemic nature of Long COVID and the economic and public health implications underscore the importance of continued research in this area. Gerlach’s framework for prioritising treatments thus provides practical guidance for clinicians in a multimodal approach, including in conjunction with Inuspheresis®, while his ongoing international research projects are helping to further deepen our understanding of this challenging condition.

Learn more about the central mechanisms of Covid/Long Covid based on current research – and discover how a multimodal therapeutic approach in combination with Inuspheresis® treatment can provide targeted support.

You can enter your questions during the keynote presentation via the chat. We will try to answer as many questions as possible during the Q&A session. Alternatively, you can contact us during the Q&A so that we can unlock your microphone and you can ask your question directly.